Suggested Readings

Caregiver Toolkit

2023 Alzheimer’s disease facts and figures. 

Alzheimer’s Association.

The Alzheimer's disease clinical spectrum: diagnosis and management.

Atri A. Med Clin North Am. 2019;103(2):263-293.

Integrating family caregivers of people with Alzheimer's disease and dementias into clinical appointments: identifying potential best practices.

Griffin JM, Riffin C, Havyer RD, et al. J Appl Gerontol. 2020;39(11):1184-1194.

Primary care practitioner perspectives on the role of primary care in dementia diagnosis and care.

Sideman AB, Ma M, Hernandez de Jesus A, et al. JAMA Netw Open. 2023;6(9):e2336030-e2336030.

Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial.

Sims JR, Zimmer JA, Evans CD, et al. JAMA. 2023;330(6):512-527.

Lecanemab in early Alzheimer’s disease.

van Dyck CH, Swanson CJ, Aisen P, et al. N Engl J Med. 2023;388(1):9-21.

Clinical impact of microbleeds in patients with Alzheimer’s disease.

Vázquez-Justes D, Aguirregoicoa I, Fernandez L, et al. BMC Geriatrics. 2022;22(1):774.

Clinical Practice Guidelines

Lecanemab: appropriate use recommendations.

Cummings J, Apostolova L, Rabinovici GD, et al. J Prev Alzheimers Dis. 2023;10(3):362-377.

Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer’s Association Workgroup National Institute on Aging and the Alzheimer’s Association (NIA-AA)

International consensus on the use of tau PET imaging agent 18F-flortaucipir in Alzheimer’s disease.

Tian M, Civelek AC, Carrio I, et al. Eur J Nucl Med Mol Imaging. 2022;49(3):895-904.

International Nuclear Medicine Consensus on the clinical use of amyloid positron emission tomography in Alzheimer’s disease.

Tian M, Zuo C, Civelek AC, et al. Phenomics. 2023;3(4):375-389.

Related activities
Webcast Series 
0.25 CME/CE

First Steps Toward Early Diagnosis of MCI or AD

Module 1

Faculty: Sharon Cohen, MD, FRCPC; Charles P. Vega, MD, FAAFP
Release: 04/29/2024
Expiration: 04/29/2025
Webcast Series 
0.25 CME/CE

When Is It Time to Refer to a Neurologist

Module 2

Faculty: Sharon Cohen, MD, FRCPC; Charles P. Vega, MD, FAAFP
Release: 05/13/2024
Expiration: 05/13/2025
Webcast Series 
0.25 CME/CE

Educating Patients and Caregivers About Targeted Therapies for Early AD

Module 3

Faculty: Sharon Cohen, MD, FRCPC; Eric G. Tangalos, MD, FACP, AGSF, CMD
Release: 05/27/2024
Expiration: 05/27/2025
Webcast Series 
0.25 CME/CE

Is the Patient a Candidate for an Antiamyloid Targeted Therapy?

Module 4

Faculty: Sharon Cohen, MD, FRCPC; Eric G. Tangalos, MD, FACP, AGSF, CMD
Release: 06/10/2024
Expiration: 06/10/2025
Webcast Series 
0.25 CME/CE

Managing AEs of Antiamyloid Therapies

Module 5

Faculty: Sharon Cohen, MD, FRCPC; Alireza Atri, MD, PhD
Release: 07/01/2024
Expiration: 07/01/2025
Webcast Series 
0.25 CME/CE

Updates to Clinic Infrastructure and Protocols

Module 6

Faculty: Sharon Cohen, MD, FRCPC; Alireza Atri, MD, PhD
Release: 07/15/2024
Expiration: 07/15/2025